Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen Mechanisms


CHROMONE derivatives exhibiting unusual biological activity have been studied in these laboratories for several years. One of these, disodium cromoglycate (FPL 670), has been found to inhibit specifically the liberation of the mediators of anaphylaxis initiated by the interaction of antigen with reagin type antibodies. It is neither a bronchodilator nor an anti-inflammatory agent and its action is distinct from that of corticosteroids.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Altounyan, R. E. C., Acta Allergologica (in the press).

  2. 2

    Howell, J. B. L., and Altounyan, R. E. C., Lancet, ii, 539 (1967).

  3. 3

    Mota, I., Life Sci., 1, 465; ibid., 917 (1963).

    Article  Google Scholar 

  4. 4

    Ogilvie, B. M., Nature, 204, 91 (1964).

    ADS  CAS  Article  Google Scholar 

  5. 5

    Sheard, P., Killingback, P. G., and Blair, A. M. J. N., Nature, 216, 283 (1967).

    ADS  CAS  Article  Google Scholar 

Download references

Author information



Rights and permissions

Reprints and Permissions

About this article

Cite this article

COX, J. Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen Mechanisms. Nature 216, 1328–1329 (1967). https://doi.org/10.1038/2161328a0

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.